nodes	percent_of_prediction	percent_of_DWPC	metapath
Progesterone—ESR1—liver cancer	0.202	0.556	CbGaD
Progesterone—CYP1A1—liver cancer	0.161	0.444	CbGaD
Progesterone—ABCC1—Epirubicin—liver cancer	0.0553	0.164	CbGbCtD
Progesterone—ABCB11—Doxorubicin—liver cancer	0.0414	0.122	CbGbCtD
Progesterone—CYP1B1—Doxorubicin—liver cancer	0.0414	0.122	CbGbCtD
Progesterone—ABCC1—Doxorubicin—liver cancer	0.0294	0.0869	CbGbCtD
Progesterone—SLC10A1—bile canaliculus—liver cancer	0.0274	0.293	CbGeAlD
Progesterone—ABCB11—bile canaliculus—liver cancer	0.0271	0.29	CbGeAlD
Progesterone—CYP3A7—Sorafenib—liver cancer	0.0239	0.0708	CbGbCtD
Progesterone—CYP3A7-CYP3A51P—Sorafenib—liver cancer	0.0239	0.0708	CbGbCtD
Progesterone—CYP3A5—Sorafenib—liver cancer	0.018	0.0531	CbGbCtD
Progesterone—CYP2C8—Sorafenib—liver cancer	0.0173	0.0511	CbGbCtD
Progesterone—CYP2C19—Sorafenib—liver cancer	0.0145	0.0428	CbGbCtD
Progesterone—CYP1A2—Sorafenib—liver cancer	0.0134	0.0395	CbGbCtD
Progesterone—CYP2C9—Sorafenib—liver cancer	0.012	0.0356	CbGbCtD
Progesterone—ABCB1—Sorafenib—liver cancer	0.0117	0.0346	CbGbCtD
Progesterone—CYP2D6—Sorafenib—liver cancer	0.011	0.0326	CbGbCtD
Progesterone—SLC10A1—bile duct—liver cancer	0.00856	0.0916	CbGeAlD
Progesterone—ABCB11—bile duct—liver cancer	0.00846	0.0905	CbGeAlD
Progesterone—ABCB1—Doxorubicin—liver cancer	0.00709	0.021	CbGbCtD
Progesterone—CYP3A4—Sorafenib—liver cancer	0.007	0.0207	CbGbCtD
Progesterone—CYP2D6—Doxorubicin—liver cancer	0.00668	0.0198	CbGbCtD
Progesterone—SLC10A1—bile—liver cancer	0.00658	0.0704	CbGeAlD
Progesterone—ABCB11—bile—liver cancer	0.0065	0.0696	CbGeAlD
Progesterone—CYP3A4—Doxorubicin—liver cancer	0.00425	0.0126	CbGbCtD
Progesterone—SLC22A3—embryo—liver cancer	0.00062	0.00663	CbGeAlD
Progesterone—SLC10A1—liver—liver cancer	0.000535	0.00573	CbGeAlD
Progesterone—ESR1—embryo—liver cancer	0.00053	0.00567	CbGeAlD
Progesterone—ABCB11—liver—liver cancer	0.000529	0.00566	CbGeAlD
Progesterone—CYP3A7—liver—liver cancer	0.000518	0.00554	CbGeAlD
Progesterone—Ethynodiol—ESR1—liver cancer	0.000471	0.187	CrCbGaD
Progesterone—CYP17A1—liver—liver cancer	0.000466	0.00499	CbGeAlD
Progesterone—CYP3A7-CYP3A51P—liver—liver cancer	0.00044	0.00471	CbGeAlD
Progesterone—Trilostane—ESR1—liver cancer	0.000433	0.172	CrCbGaD
Progesterone—Norgestimate—ESR1—liver cancer	0.0004	0.159	CrCbGaD
Progesterone—NR3C1—embryo—liver cancer	0.000391	0.00418	CbGeAlD
Progesterone—CYP2A6—liver—liver cancer	0.00036	0.00385	CbGeAlD
Progesterone—SHBG—liver—liver cancer	0.000348	0.00372	CbGeAlD
Progesterone—NR3C2—liver—liver cancer	0.000337	0.0036	CbGeAlD
Progesterone—SLC22A1—liver—liver cancer	0.0003	0.00321	CbGeAlD
Progesterone—SLC22A3—liver—liver cancer	0.000287	0.00307	CbGeAlD
Progesterone—SIGMAR1—liver—liver cancer	0.000277	0.00296	CbGeAlD
Progesterone—CYP1B1—liver—liver cancer	0.000264	0.00282	CbGeAlD
Progesterone—AR—liver—liver cancer	0.00025	0.00267	CbGeAlD
Progesterone—Levonorgestrel—ESR1—liver cancer	0.000245	0.0974	CrCbGaD
Progesterone—ESR1—liver—liver cancer	0.000245	0.00262	CbGeAlD
Progesterone—ABCC1—liver—liver cancer	0.000237	0.00254	CbGeAlD
Progesterone—Fluoxymesterone—ESR1—liver cancer	0.000234	0.0929	CrCbGaD
Progesterone—CYP2C19—liver—liver cancer	0.000231	0.00247	CbGeAlD
Progesterone—Danazol—ESR1—liver cancer	0.000223	0.0888	CrCbGaD
Progesterone—ABCB1—embryo—liver cancer	0.000209	0.00224	CbGeAlD
Progesterone—CYP2C8—liver—liver cancer	0.000202	0.00216	CbGeAlD
Progesterone—Medroxyprogesterone Acetate—ESR1—liver cancer	0.0002	0.0797	CrCbGaD
Progesterone—Body temperature increased—Sorafenib—liver cancer	0.00019	0.00207	CcSEcCtD
Progesterone—CYP1A2—liver—liver cancer	0.000189	0.00202	CbGeAlD
Progesterone—Purpura—Epirubicin—liver cancer	0.000188	0.00204	CcSEcCtD
Progesterone—Vascular purpura—Doxorubicin—liver cancer	0.000187	0.00204	CcSEcCtD
Progesterone—Anaphylactoid reaction—Epirubicin—liver cancer	0.000187	0.00204	CcSEcCtD
Progesterone—CYP1A1—liver—liver cancer	0.000186	0.00199	CbGeAlD
Progesterone—Hepatic failure—Doxorubicin—liver cancer	0.000186	0.00203	CcSEcCtD
Progesterone—CYP3A5—liver—liver cancer	0.000182	0.00195	CbGeAlD
Progesterone—Pain in extremity—Epirubicin—liver cancer	0.000181	0.00197	CcSEcCtD
Progesterone—Osteoarthritis—Epirubicin—liver cancer	0.000181	0.00197	CcSEcCtD
Progesterone—Diplopia—Epirubicin—liver cancer	0.000181	0.00197	CcSEcCtD
Progesterone—NR3C1—liver—liver cancer	0.000181	0.00193	CbGeAlD
Progesterone—CYP2C9—liver—liver cancer	0.000179	0.00192	CbGeAlD
Progesterone—Hot flush—Doxorubicin—liver cancer	0.000179	0.00195	CcSEcCtD
Progesterone—Increased appetite—Doxorubicin—liver cancer	0.000178	0.00194	CcSEcCtD
Progesterone—Migraine—Epirubicin—liver cancer	0.000178	0.00194	CcSEcCtD
Progesterone—Affect lability—Epirubicin—liver cancer	0.000178	0.00194	CcSEcCtD
Progesterone—Menopausal symptoms—Doxorubicin—liver cancer	0.000177	0.00193	CcSEcCtD
Progesterone—Hypersensitivity—Sorafenib—liver cancer	0.000177	0.00193	CcSEcCtD
Progesterone—Face oedema—Epirubicin—liver cancer	0.000175	0.0019	CcSEcCtD
Progesterone—Purpura—Doxorubicin—liver cancer	0.000174	0.00189	CcSEcCtD
Progesterone—Anaphylactoid reaction—Doxorubicin—liver cancer	0.000173	0.00188	CcSEcCtD
Progesterone—Asthenia—Sorafenib—liver cancer	0.000172	0.00188	CcSEcCtD
Progesterone—Mood swings—Epirubicin—liver cancer	0.000171	0.00187	CcSEcCtD
Progesterone—Pruritus—Sorafenib—liver cancer	0.00017	0.00185	CcSEcCtD
Progesterone—Osteoarthritis—Doxorubicin—liver cancer	0.000167	0.00182	CcSEcCtD
Progesterone—Diplopia—Doxorubicin—liver cancer	0.000167	0.00182	CcSEcCtD
Progesterone—Pain in extremity—Doxorubicin—liver cancer	0.000167	0.00182	CcSEcCtD
Progesterone—Liver function test abnormal—Epirubicin—liver cancer	0.000167	0.00182	CcSEcCtD
Progesterone—Affect lability—Doxorubicin—liver cancer	0.000165	0.00179	CcSEcCtD
Progesterone—Migraine—Doxorubicin—liver cancer	0.000165	0.00179	CcSEcCtD
Progesterone—Diarrhoea—Sorafenib—liver cancer	0.000164	0.00179	CcSEcCtD
Progesterone—Breast disorder—Epirubicin—liver cancer	0.000163	0.00178	CcSEcCtD
Progesterone—Aspartate aminotransferase increased—Epirubicin—liver cancer	0.000163	0.00177	CcSEcCtD
Progesterone—Nasopharyngitis—Epirubicin—liver cancer	0.000162	0.00176	CcSEcCtD
Progesterone—Face oedema—Doxorubicin—liver cancer	0.000161	0.00176	CcSEcCtD
Progesterone—Gastritis—Epirubicin—liver cancer	0.00016	0.00174	CcSEcCtD
Progesterone—Alanine aminotransferase increased—Epirubicin—liver cancer	0.000159	0.00174	CcSEcCtD
Progesterone—Dizziness—Sorafenib—liver cancer	0.000159	0.00173	CcSEcCtD
Progesterone—Mood swings—Doxorubicin—liver cancer	0.000158	0.00173	CcSEcCtD
Progesterone—Abdominal distension—Epirubicin—liver cancer	0.000157	0.00171	CcSEcCtD
Progesterone—Asthma—Epirubicin—liver cancer	0.000156	0.0017	CcSEcCtD
Progesterone—Dysphagia—Epirubicin—liver cancer	0.000156	0.0017	CcSEcCtD
Progesterone—Liver function test abnormal—Doxorubicin—liver cancer	0.000154	0.00168	CcSEcCtD
Progesterone—Vomiting—Sorafenib—liver cancer	0.000153	0.00167	CcSEcCtD
Progesterone—Angina pectoris—Epirubicin—liver cancer	0.000152	0.00166	CcSEcCtD
Progesterone—Rash—Sorafenib—liver cancer	0.000152	0.00165	CcSEcCtD
Progesterone—Dermatitis—Sorafenib—liver cancer	0.000151	0.00165	CcSEcCtD
Progesterone—Breast disorder—Doxorubicin—liver cancer	0.000151	0.00165	CcSEcCtD
Progesterone—Aspartate aminotransferase increased—Doxorubicin—liver cancer	0.000151	0.00164	CcSEcCtD
Progesterone—Headache—Sorafenib—liver cancer	0.000151	0.00164	CcSEcCtD
Progesterone—Bronchitis—Epirubicin—liver cancer	0.00015	0.00164	CcSEcCtD
Progesterone—Nasopharyngitis—Doxorubicin—liver cancer	0.00015	0.00163	CcSEcCtD
Progesterone—Gastritis—Doxorubicin—liver cancer	0.000148	0.00161	CcSEcCtD
Progesterone—Alanine aminotransferase increased—Doxorubicin—liver cancer	0.000148	0.00161	CcSEcCtD
Progesterone—Dysuria—Epirubicin—liver cancer	0.000146	0.00159	CcSEcCtD
Progesterone—Abdominal distension—Doxorubicin—liver cancer	0.000146	0.00159	CcSEcCtD
Progesterone—Upper respiratory tract infection—Epirubicin—liver cancer	0.000145	0.00158	CcSEcCtD
Progesterone—Asthma—Doxorubicin—liver cancer	0.000145	0.00158	CcSEcCtD
Progesterone—Dysphagia—Doxorubicin—liver cancer	0.000145	0.00158	CcSEcCtD
Progesterone—Pollakiuria—Epirubicin—liver cancer	0.000144	0.00157	CcSEcCtD
Progesterone—Nausea—Sorafenib—liver cancer	0.000143	0.00156	CcSEcCtD
Progesterone—Weight increased—Epirubicin—liver cancer	0.000142	0.00155	CcSEcCtD
Progesterone—Weight decreased—Epirubicin—liver cancer	0.000141	0.00154	CcSEcCtD
Progesterone—Hyperglycaemia—Epirubicin—liver cancer	0.000141	0.00154	CcSEcCtD
Progesterone—Angina pectoris—Doxorubicin—liver cancer	0.000141	0.00154	CcSEcCtD
Progesterone—Pneumonia—Epirubicin—liver cancer	0.00014	0.00153	CcSEcCtD
Progesterone—Drowsiness—Epirubicin—liver cancer	0.000139	0.00152	CcSEcCtD
Progesterone—Infestation NOS—Epirubicin—liver cancer	0.000139	0.00152	CcSEcCtD
Progesterone—Infestation—Epirubicin—liver cancer	0.000139	0.00152	CcSEcCtD
Progesterone—Bronchitis—Doxorubicin—liver cancer	0.000139	0.00152	CcSEcCtD
Progesterone—CYP3A4—liver—liver cancer	0.000137	0.00146	CbGeAlD
Progesterone—Neuropathy peripheral—Epirubicin—liver cancer	0.000137	0.00149	CcSEcCtD
Progesterone—Jaundice—Epirubicin—liver cancer	0.000136	0.00148	CcSEcCtD
Progesterone—Urinary tract infection—Epirubicin—liver cancer	0.000135	0.00148	CcSEcCtD
Progesterone—Conjunctivitis—Epirubicin—liver cancer	0.000135	0.00148	CcSEcCtD
Progesterone—Dysuria—Doxorubicin—liver cancer	0.000135	0.00147	CcSEcCtD
Progesterone—CYP2D6—liver—liver cancer	0.000135	0.00144	CbGeAlD
Progesterone—Upper respiratory tract infection—Doxorubicin—liver cancer	0.000134	0.00146	CcSEcCtD
Progesterone—Pollakiuria—Doxorubicin—liver cancer	0.000134	0.00146	CcSEcCtD
Progesterone—Hepatobiliary disease—Epirubicin—liver cancer	0.000132	0.00144	CcSEcCtD
Progesterone—Weight increased—Doxorubicin—liver cancer	0.000132	0.00143	CcSEcCtD
Progesterone—Weight decreased—Doxorubicin—liver cancer	0.000131	0.00143	CcSEcCtD
Progesterone—Sinusitis—Epirubicin—liver cancer	0.000131	0.00142	CcSEcCtD
Progesterone—Hyperglycaemia—Doxorubicin—liver cancer	0.00013	0.00142	CcSEcCtD
Progesterone—Pneumonia—Doxorubicin—liver cancer	0.00013	0.00141	CcSEcCtD
Progesterone—Infestation—Doxorubicin—liver cancer	0.000129	0.00141	CcSEcCtD
Progesterone—Infestation NOS—Doxorubicin—liver cancer	0.000129	0.00141	CcSEcCtD
Progesterone—Drowsiness—Doxorubicin—liver cancer	0.000129	0.00141	CcSEcCtD
Progesterone—Neuropathy peripheral—Doxorubicin—liver cancer	0.000126	0.00138	CcSEcCtD
Progesterone—Haemoglobin—Epirubicin—liver cancer	0.000126	0.00137	CcSEcCtD
Progesterone—Jaundice—Doxorubicin—liver cancer	0.000126	0.00137	CcSEcCtD
Progesterone—Rhinitis—Epirubicin—liver cancer	0.000125	0.00137	CcSEcCtD
Progesterone—Conjunctivitis—Doxorubicin—liver cancer	0.000125	0.00137	CcSEcCtD
Progesterone—Urinary tract infection—Doxorubicin—liver cancer	0.000125	0.00137	CcSEcCtD
Progesterone—Haemorrhage—Epirubicin—liver cancer	0.000125	0.00136	CcSEcCtD
Progesterone—Hepatitis—Epirubicin—liver cancer	0.000125	0.00136	CcSEcCtD
Progesterone—Pharyngitis—Epirubicin—liver cancer	0.000124	0.00135	CcSEcCtD
Progesterone—Urinary tract disorder—Epirubicin—liver cancer	0.000123	0.00135	CcSEcCtD
Progesterone—Oedema peripheral—Epirubicin—liver cancer	0.000123	0.00134	CcSEcCtD
Progesterone—Connective tissue disorder—Epirubicin—liver cancer	0.000123	0.00134	CcSEcCtD
Progesterone—Urethral disorder—Epirubicin—liver cancer	0.000123	0.00134	CcSEcCtD
Progesterone—Hepatobiliary disease—Doxorubicin—liver cancer	0.000122	0.00133	CcSEcCtD
Progesterone—Sinusitis—Doxorubicin—liver cancer	0.000121	0.00132	CcSEcCtD
Progesterone—Visual impairment—Epirubicin—liver cancer	0.000121	0.00131	CcSEcCtD
Progesterone—Erythema multiforme—Epirubicin—liver cancer	0.000118	0.00129	CcSEcCtD
Progesterone—Eye disorder—Epirubicin—liver cancer	0.000117	0.00127	CcSEcCtD
Progesterone—Tinnitus—Epirubicin—liver cancer	0.000117	0.00127	CcSEcCtD
Progesterone—Haemoglobin—Doxorubicin—liver cancer	0.000116	0.00127	CcSEcCtD
Progesterone—Cardiac disorder—Epirubicin—liver cancer	0.000116	0.00127	CcSEcCtD
Progesterone—Rhinitis—Doxorubicin—liver cancer	0.000116	0.00126	CcSEcCtD
Progesterone—Hepatitis—Doxorubicin—liver cancer	0.000116	0.00126	CcSEcCtD
Progesterone—Haemorrhage—Doxorubicin—liver cancer	0.000116	0.00126	CcSEcCtD
Progesterone—Pharyngitis—Doxorubicin—liver cancer	0.000115	0.00125	CcSEcCtD
Progesterone—Urinary tract disorder—Doxorubicin—liver cancer	0.000114	0.00125	CcSEcCtD
Progesterone—Oedema peripheral—Doxorubicin—liver cancer	0.000114	0.00124	CcSEcCtD
Progesterone—Connective tissue disorder—Doxorubicin—liver cancer	0.000114	0.00124	CcSEcCtD
Progesterone—Angiopathy—Epirubicin—liver cancer	0.000113	0.00124	CcSEcCtD
Progesterone—Urethral disorder—Doxorubicin—liver cancer	0.000113	0.00124	CcSEcCtD
Progesterone—Immune system disorder—Epirubicin—liver cancer	0.000113	0.00123	CcSEcCtD
Progesterone—Mediastinal disorder—Epirubicin—liver cancer	0.000113	0.00123	CcSEcCtD
Progesterone—Visual impairment—Doxorubicin—liver cancer	0.000112	0.00122	CcSEcCtD
Progesterone—Alopecia—Epirubicin—liver cancer	0.000111	0.0012	CcSEcCtD
Progesterone—Mental disorder—Epirubicin—liver cancer	0.00011	0.00119	CcSEcCtD
Progesterone—Erythema multiforme—Doxorubicin—liver cancer	0.000109	0.00119	CcSEcCtD
Progesterone—Malnutrition—Epirubicin—liver cancer	0.000109	0.00119	CcSEcCtD
Progesterone—Erythema—Epirubicin—liver cancer	0.000109	0.00119	CcSEcCtD
Progesterone—Eye disorder—Doxorubicin—liver cancer	0.000108	0.00118	CcSEcCtD
Progesterone—Tinnitus—Doxorubicin—liver cancer	0.000108	0.00118	CcSEcCtD
Progesterone—Cardiac disorder—Doxorubicin—liver cancer	0.000107	0.00117	CcSEcCtD
Progesterone—Flatulence—Epirubicin—liver cancer	0.000107	0.00117	CcSEcCtD
Progesterone—Tension—Epirubicin—liver cancer	0.000107	0.00116	CcSEcCtD
Progesterone—Nervousness—Epirubicin—liver cancer	0.000106	0.00115	CcSEcCtD
Progesterone—Back pain—Epirubicin—liver cancer	0.000105	0.00115	CcSEcCtD
Progesterone—Angiopathy—Doxorubicin—liver cancer	0.000105	0.00114	CcSEcCtD
Progesterone—Muscle spasms—Epirubicin—liver cancer	0.000105	0.00114	CcSEcCtD
Progesterone—Immune system disorder—Doxorubicin—liver cancer	0.000105	0.00114	CcSEcCtD
Progesterone—Mediastinal disorder—Doxorubicin—liver cancer	0.000104	0.00114	CcSEcCtD
Progesterone—Vision blurred—Epirubicin—liver cancer	0.000103	0.00112	CcSEcCtD
Progesterone—Alopecia—Doxorubicin—liver cancer	0.000102	0.00111	CcSEcCtD
Progesterone—Mental disorder—Doxorubicin—liver cancer	0.000101	0.00111	CcSEcCtD
Progesterone—Ill-defined disorder—Epirubicin—liver cancer	0.000101	0.0011	CcSEcCtD
Progesterone—Malnutrition—Doxorubicin—liver cancer	0.000101	0.0011	CcSEcCtD
Progesterone—Erythema—Doxorubicin—liver cancer	0.000101	0.0011	CcSEcCtD
Progesterone—Anaemia—Epirubicin—liver cancer	0.000101	0.0011	CcSEcCtD
Progesterone—Flatulence—Doxorubicin—liver cancer	9.93e-05	0.00108	CcSEcCtD
Progesterone—Tension—Doxorubicin—liver cancer	9.88e-05	0.00108	CcSEcCtD
Progesterone—Malaise—Epirubicin—liver cancer	9.82e-05	0.00107	CcSEcCtD
Progesterone—Nervousness—Doxorubicin—liver cancer	9.78e-05	0.00107	CcSEcCtD
Progesterone—Vertigo—Epirubicin—liver cancer	9.78e-05	0.00107	CcSEcCtD
Progesterone—Syncope—Epirubicin—liver cancer	9.76e-05	0.00106	CcSEcCtD
Progesterone—Back pain—Doxorubicin—liver cancer	9.74e-05	0.00106	CcSEcCtD
Progesterone—Muscle spasms—Doxorubicin—liver cancer	9.68e-05	0.00106	CcSEcCtD
Progesterone—ABCB1—liver—liver cancer	9.68e-05	0.00104	CbGeAlD
Progesterone—Palpitations—Epirubicin—liver cancer	9.62e-05	0.00105	CcSEcCtD
Progesterone—Loss of consciousness—Epirubicin—liver cancer	9.57e-05	0.00104	CcSEcCtD
Progesterone—Cough—Epirubicin—liver cancer	9.5e-05	0.00104	CcSEcCtD
Progesterone—Vision blurred—Doxorubicin—liver cancer	9.49e-05	0.00103	CcSEcCtD
Progesterone—Convulsion—Epirubicin—liver cancer	9.43e-05	0.00103	CcSEcCtD
Progesterone—Hypertension—Epirubicin—liver cancer	9.4e-05	0.00102	CcSEcCtD
Progesterone—Ill-defined disorder—Doxorubicin—liver cancer	9.35e-05	0.00102	CcSEcCtD
Progesterone—Anaemia—Doxorubicin—liver cancer	9.31e-05	0.00101	CcSEcCtD
Progesterone—Chest pain—Epirubicin—liver cancer	9.27e-05	0.00101	CcSEcCtD
Progesterone—Myalgia—Epirubicin—liver cancer	9.27e-05	0.00101	CcSEcCtD
Progesterone—Arthralgia—Epirubicin—liver cancer	9.27e-05	0.00101	CcSEcCtD
Progesterone—Anxiety—Epirubicin—liver cancer	9.24e-05	0.00101	CcSEcCtD
Progesterone—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—liver cancer	9.2e-05	0.001	CcSEcCtD
Progesterone—Discomfort—Epirubicin—liver cancer	9.16e-05	0.000998	CcSEcCtD
Progesterone—Malaise—Doxorubicin—liver cancer	9.08e-05	0.00099	CcSEcCtD
Progesterone—Dry mouth—Epirubicin—liver cancer	9.06e-05	0.000988	CcSEcCtD
Progesterone—Vertigo—Doxorubicin—liver cancer	9.05e-05	0.000987	CcSEcCtD
Progesterone—Syncope—Doxorubicin—liver cancer	9.03e-05	0.000985	CcSEcCtD
Progesterone—Confusional state—Epirubicin—liver cancer	8.96e-05	0.000977	CcSEcCtD
Progesterone—Palpitations—Doxorubicin—liver cancer	8.9e-05	0.00097	CcSEcCtD
Progesterone—Oedema—Epirubicin—liver cancer	8.88e-05	0.000969	CcSEcCtD
Progesterone—Anaphylactic shock—Epirubicin—liver cancer	8.88e-05	0.000969	CcSEcCtD
Progesterone—Loss of consciousness—Doxorubicin—liver cancer	8.85e-05	0.000965	CcSEcCtD
Progesterone—Norethindrone—ALB—liver cancer	8.84e-05	0.0352	CrCbGaD
Progesterone—Infection—Epirubicin—liver cancer	8.83e-05	0.000962	CcSEcCtD
Progesterone—Cough—Doxorubicin—liver cancer	8.79e-05	0.000958	CcSEcCtD
Progesterone—Testosterone—CYP1A1—liver cancer	8.75e-05	0.0348	CrCbGaD
Progesterone—Shock—Epirubicin—liver cancer	8.74e-05	0.000953	CcSEcCtD
Progesterone—Convulsion—Doxorubicin—liver cancer	8.73e-05	0.000951	CcSEcCtD
Progesterone—Nervous system disorder—Epirubicin—liver cancer	8.71e-05	0.00095	CcSEcCtD
Progesterone—Hypertension—Doxorubicin—liver cancer	8.7e-05	0.000948	CcSEcCtD
Progesterone—Tachycardia—Epirubicin—liver cancer	8.67e-05	0.000945	CcSEcCtD
Progesterone—Skin disorder—Epirubicin—liver cancer	8.63e-05	0.000941	CcSEcCtD
Progesterone—Hyperhidrosis—Epirubicin—liver cancer	8.59e-05	0.000936	CcSEcCtD
Progesterone—Arthralgia—Doxorubicin—liver cancer	8.58e-05	0.000935	CcSEcCtD
Progesterone—Chest pain—Doxorubicin—liver cancer	8.58e-05	0.000935	CcSEcCtD
Progesterone—Myalgia—Doxorubicin—liver cancer	8.58e-05	0.000935	CcSEcCtD
Progesterone—Anxiety—Doxorubicin—liver cancer	8.55e-05	0.000932	CcSEcCtD
Progesterone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—liver cancer	8.52e-05	0.000928	CcSEcCtD
Progesterone—Discomfort—Doxorubicin—liver cancer	8.47e-05	0.000924	CcSEcCtD
Progesterone—Anorexia—Epirubicin—liver cancer	8.47e-05	0.000923	CcSEcCtD
Progesterone—Methyltestosterone—ALB—liver cancer	8.4e-05	0.0334	CrCbGaD
Progesterone—Dry mouth—Doxorubicin—liver cancer	8.39e-05	0.000914	CcSEcCtD
Progesterone—Hypotension—Epirubicin—liver cancer	8.3e-05	0.000905	CcSEcCtD
Progesterone—Confusional state—Doxorubicin—liver cancer	8.29e-05	0.000904	CcSEcCtD
Progesterone—Oedema—Doxorubicin—liver cancer	8.22e-05	0.000896	CcSEcCtD
Progesterone—Anaphylactic shock—Doxorubicin—liver cancer	8.22e-05	0.000896	CcSEcCtD
Progesterone—Infection—Doxorubicin—liver cancer	8.17e-05	0.00089	CcSEcCtD
Progesterone—Musculoskeletal discomfort—Epirubicin—liver cancer	8.09e-05	0.000882	CcSEcCtD
Progesterone—Shock—Doxorubicin—liver cancer	8.09e-05	0.000882	CcSEcCtD
Progesterone—Nervous system disorder—Doxorubicin—liver cancer	8.06e-05	0.000879	CcSEcCtD
Progesterone—Insomnia—Epirubicin—liver cancer	8.04e-05	0.000876	CcSEcCtD
Progesterone—Tachycardia—Doxorubicin—liver cancer	8.02e-05	0.000875	CcSEcCtD
Progesterone—Skin disorder—Doxorubicin—liver cancer	7.98e-05	0.00087	CcSEcCtD
Progesterone—Paraesthesia—Epirubicin—liver cancer	7.98e-05	0.00087	CcSEcCtD
Progesterone—Hyperhidrosis—Doxorubicin—liver cancer	7.95e-05	0.000866	CcSEcCtD
Progesterone—Dyspnoea—Epirubicin—liver cancer	7.92e-05	0.000863	CcSEcCtD
Progesterone—Somnolence—Epirubicin—liver cancer	7.9e-05	0.000861	CcSEcCtD
Progesterone—Anorexia—Doxorubicin—liver cancer	7.84e-05	0.000854	CcSEcCtD
Progesterone—Dyspepsia—Epirubicin—liver cancer	7.82e-05	0.000853	CcSEcCtD
Progesterone—Decreased appetite—Epirubicin—liver cancer	7.72e-05	0.000842	CcSEcCtD
Progesterone—Hypotension—Doxorubicin—liver cancer	7.68e-05	0.000837	CcSEcCtD
Progesterone—Gastrointestinal disorder—Epirubicin—liver cancer	7.67e-05	0.000836	CcSEcCtD
Progesterone—Fatigue—Epirubicin—liver cancer	7.66e-05	0.000835	CcSEcCtD
Progesterone—Constipation—Epirubicin—liver cancer	7.6e-05	0.000828	CcSEcCtD
Progesterone—Pain—Epirubicin—liver cancer	7.6e-05	0.000828	CcSEcCtD
Progesterone—Musculoskeletal discomfort—Doxorubicin—liver cancer	7.49e-05	0.000816	CcSEcCtD
Progesterone—Insomnia—Doxorubicin—liver cancer	7.44e-05	0.000811	CcSEcCtD
Progesterone—Paraesthesia—Doxorubicin—liver cancer	7.38e-05	0.000805	CcSEcCtD
Progesterone—Dyspnoea—Doxorubicin—liver cancer	7.33e-05	0.000799	CcSEcCtD
Progesterone—Feeling abnormal—Epirubicin—liver cancer	7.32e-05	0.000798	CcSEcCtD
Progesterone—Somnolence—Doxorubicin—liver cancer	7.31e-05	0.000797	CcSEcCtD
Progesterone—Gastrointestinal pain—Epirubicin—liver cancer	7.26e-05	0.000792	CcSEcCtD
Progesterone—Dyspepsia—Doxorubicin—liver cancer	7.24e-05	0.000789	CcSEcCtD
Progesterone—Decreased appetite—Doxorubicin—liver cancer	7.15e-05	0.000779	CcSEcCtD
Progesterone—Gastrointestinal disorder—Doxorubicin—liver cancer	7.1e-05	0.000774	CcSEcCtD
Progesterone—Fatigue—Doxorubicin—liver cancer	7.09e-05	0.000773	CcSEcCtD
Progesterone—Urticaria—Epirubicin—liver cancer	7.06e-05	0.000769	CcSEcCtD
Progesterone—Pain—Doxorubicin—liver cancer	7.03e-05	0.000766	CcSEcCtD
Progesterone—Constipation—Doxorubicin—liver cancer	7.03e-05	0.000766	CcSEcCtD
Progesterone—Abdominal pain—Epirubicin—liver cancer	7.02e-05	0.000766	CcSEcCtD
Progesterone—Body temperature increased—Epirubicin—liver cancer	7.02e-05	0.000766	CcSEcCtD
Progesterone—Feeling abnormal—Doxorubicin—liver cancer	6.77e-05	0.000738	CcSEcCtD
Progesterone—Gastrointestinal pain—Doxorubicin—liver cancer	6.72e-05	0.000733	CcSEcCtD
Progesterone—Hypersensitivity—Epirubicin—liver cancer	6.55e-05	0.000714	CcSEcCtD
Progesterone—Urticaria—Doxorubicin—liver cancer	6.53e-05	0.000712	CcSEcCtD
Progesterone—Abdominal pain—Doxorubicin—liver cancer	6.5e-05	0.000708	CcSEcCtD
Progesterone—Body temperature increased—Doxorubicin—liver cancer	6.5e-05	0.000708	CcSEcCtD
Progesterone—Asthenia—Epirubicin—liver cancer	6.37e-05	0.000695	CcSEcCtD
Progesterone—Pruritus—Epirubicin—liver cancer	6.29e-05	0.000685	CcSEcCtD
Progesterone—Diarrhoea—Epirubicin—liver cancer	6.08e-05	0.000663	CcSEcCtD
Progesterone—Hypersensitivity—Doxorubicin—liver cancer	6.06e-05	0.00066	CcSEcCtD
Progesterone—Asthenia—Doxorubicin—liver cancer	5.9e-05	0.000643	CcSEcCtD
Progesterone—Dizziness—Epirubicin—liver cancer	5.87e-05	0.00064	CcSEcCtD
Progesterone—Pruritus—Doxorubicin—liver cancer	5.82e-05	0.000634	CcSEcCtD
Progesterone—Vomiting—Epirubicin—liver cancer	5.65e-05	0.000616	CcSEcCtD
Progesterone—Diarrhoea—Doxorubicin—liver cancer	5.62e-05	0.000613	CcSEcCtD
Progesterone—Rash—Epirubicin—liver cancer	5.6e-05	0.000611	CcSEcCtD
Progesterone—Dermatitis—Epirubicin—liver cancer	5.6e-05	0.00061	CcSEcCtD
Progesterone—Headache—Epirubicin—liver cancer	5.57e-05	0.000607	CcSEcCtD
Progesterone—Dizziness—Doxorubicin—liver cancer	5.44e-05	0.000593	CcSEcCtD
Progesterone—Nausea—Epirubicin—liver cancer	5.28e-05	0.000575	CcSEcCtD
Progesterone—Vomiting—Doxorubicin—liver cancer	5.23e-05	0.00057	CcSEcCtD
Progesterone—Rash—Doxorubicin—liver cancer	5.18e-05	0.000565	CcSEcCtD
Progesterone—Dermatitis—Doxorubicin—liver cancer	5.18e-05	0.000565	CcSEcCtD
Progesterone—Headache—Doxorubicin—liver cancer	5.15e-05	0.000561	CcSEcCtD
Progesterone—Nausea—Doxorubicin—liver cancer	4.88e-05	0.000532	CcSEcCtD
Progesterone—Testosterone—ALB—liver cancer	4.87e-05	0.0194	CrCbGaD
Progesterone—ABCB1—Metabolism—GGT1—liver cancer	3.68e-06	3.3e-05	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—GOT1—liver cancer	3.68e-06	3.3e-05	CbGpPWpGaD
Progesterone—CYP17A1—Metabolism—PIK3CA—liver cancer	3.67e-06	3.29e-05	CbGpPWpGaD
Progesterone—CYP2A6—Metabolism—PPARG—liver cancer	3.66e-06	3.28e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—MTOR—liver cancer	3.65e-06	3.27e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—PIK3CB—liver cancer	3.65e-06	3.27e-05	CbGpPWpGaD
Progesterone—CYP3A7—Metabolism—PIK3CD—liver cancer	3.64e-06	3.26e-05	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—ALDOB—liver cancer	3.63e-06	3.26e-05	CbGpPWpGaD
Progesterone—ABCC1—Metabolism—PIK3CB—liver cancer	3.63e-06	3.26e-05	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—VEGFA—liver cancer	3.63e-06	3.26e-05	CbGpPWpGaD
Progesterone—SLC22A2—Metabolism—PIK3CD—liver cancer	3.63e-06	3.26e-05	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	3.63e-06	3.25e-05	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—STAT3—liver cancer	3.6e-06	3.23e-05	CbGpPWpGaD
Progesterone—CYP3A7—Metabolism—ALB—liver cancer	3.59e-06	3.22e-05	CbGpPWpGaD
Progesterone—SLC22A2—Metabolism—ALB—liver cancer	3.58e-06	3.21e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—PIK3CG—liver cancer	3.57e-06	3.2e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—APC—liver cancer	3.57e-06	3.2e-05	CbGpPWpGaD
Progesterone—PGR—Gene Expression—AKT1—liver cancer	3.57e-06	3.2e-05	CbGpPWpGaD
Progesterone—CYP3A5—Metabolism—MTHFR—liver cancer	3.56e-06	3.19e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	3.56e-06	3.19e-05	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—CYCS—liver cancer	3.54e-06	3.17e-05	CbGpPWpGaD
Progesterone—CYP1B1—Metabolism—PIK3CB—liver cancer	3.51e-06	3.15e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism of lipids and lipoproteins—ALB—liver cancer	3.51e-06	3.15e-05	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—CYCS—liver cancer	3.5e-06	3.14e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—PSMA4—liver cancer	3.5e-06	3.14e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—PSMD10—liver cancer	3.5e-06	3.14e-05	CbGpPWpGaD
Progesterone—CYP3A5—Metabolism—PPARA—liver cancer	3.49e-06	3.13e-05	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism—GSTM1—liver cancer	3.49e-06	3.13e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling by GPCR—HRAS—liver cancer	3.48e-06	3.12e-05	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—GGT1—liver cancer	3.47e-06	3.11e-05	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—GOT1—liver cancer	3.47e-06	3.11e-05	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—CRABP1—liver cancer	3.47e-06	3.11e-05	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—GOT1—liver cancer	3.44e-06	3.08e-05	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—GGT1—liver cancer	3.44e-06	3.08e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—CDKN1B—liver cancer	3.42e-06	3.07e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—GOT2—liver cancer	3.4e-06	3.05e-05	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—GSTP1—liver cancer	3.39e-06	3.04e-05	CbGpPWpGaD
Progesterone—OPRK1—GPCR downstream signaling—AKT1—liver cancer	3.38e-06	3.04e-05	CbGpPWpGaD
Progesterone—SLC22A1—Metabolism—PIK3CD—liver cancer	3.38e-06	3.03e-05	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism—MTHFR—liver cancer	3.36e-06	3.01e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—CASP3—liver cancer	3.35e-06	3.01e-05	CbGpPWpGaD
Progesterone—ABCC1—Disease—STAT3—liver cancer	3.35e-06	3.01e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—BRAF—liver cancer	3.35e-06	3.01e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—IL2—liver cancer	3.35e-06	3e-05	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—MYC—liver cancer	3.34e-06	3e-05	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—HMOX1—liver cancer	3.34e-06	3e-05	CbGpPWpGaD
Progesterone—SLC22A1—Metabolism—ALB—liver cancer	3.34e-06	3e-05	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—TGFB1—liver cancer	3.33e-06	2.99e-05	CbGpPWpGaD
Progesterone—CYP2A6—Metabolism—PIK3CD—liver cancer	3.33e-06	2.99e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling by GPCR—IL6—liver cancer	3.33e-06	2.99e-05	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—GSTP1—liver cancer	3.31e-06	2.97e-05	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism—CYP1A1—liver cancer	3.31e-06	2.96e-05	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism—PPARA—liver cancer	3.3e-06	2.96e-05	CbGpPWpGaD
Progesterone—CYP2A6—Metabolism—ALB—liver cancer	3.29e-06	2.95e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—CCND1—liver cancer	3.26e-06	2.93e-05	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—HMOX1—liver cancer	3.26e-06	2.92e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—JUN—liver cancer	3.26e-06	2.92e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—CTNNB1—liver cancer	3.23e-06	2.9e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—CYP2E1—liver cancer	3.2e-06	2.87e-05	CbGpPWpGaD
Progesterone—CYP3A7—Metabolism—PIK3CB—liver cancer	3.17e-06	2.84e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—MMP9—liver cancer	3.17e-06	2.84e-05	CbGpPWpGaD
Progesterone—SLC22A2—Metabolism—PIK3CB—liver cancer	3.16e-06	2.84e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—CDKN1A—liver cancer	3.16e-06	2.83e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—PIK3CD—liver cancer	3.13e-06	2.81e-05	CbGpPWpGaD
Progesterone—ABCC1—Disease—MYC—liver cancer	3.12e-06	2.79e-05	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—GSTP1—liver cancer	3.12e-06	2.79e-05	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—GSTM1—liver cancer	3.11e-06	2.79e-05	CbGpPWpGaD
Progesterone—ABCC1—Disease—TGFB1—liver cancer	3.11e-06	2.79e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—SERPINE1—liver cancer	3.1e-06	2.78e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	3.1e-06	2.78e-05	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—KRAS—liver cancer	3.09e-06	2.77e-05	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—GSTP1—liver cancer	3.09e-06	2.77e-05	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism—MTHFR—liver cancer	3.08e-06	2.76e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—MAPK8—liver cancer	3.08e-06	2.76e-05	CbGpPWpGaD
Progesterone—SLC22A3—Metabolism—PIK3CA—liver cancer	3.08e-06	2.76e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling by GPCR—AKT1—liver cancer	3.07e-06	2.76e-05	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—HMOX1—liver cancer	3.07e-06	2.76e-05	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—HMOX1—liver cancer	3.05e-06	2.73e-05	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—GSTM1—liver cancer	3.04e-06	2.72e-05	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—HPGDS—liver cancer	3.03e-06	2.72e-05	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism—PPARA—liver cancer	3.02e-06	2.71e-05	CbGpPWpGaD
Progesterone—ESR1—Gene Expression—MYC—liver cancer	3.02e-06	2.71e-05	CbGpPWpGaD
Progesterone—CYP17A1—Metabolism—AKT1—liver cancer	3e-06	2.69e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—CYCS—liver cancer	2.99e-06	2.69e-05	CbGpPWpGaD
Progesterone—CYP3A5—Metabolism—PIK3CG—liver cancer	2.99e-06	2.68e-05	CbGpPWpGaD
Progesterone—NR3C1—Gene Expression—MYC—liver cancer	2.97e-06	2.67e-05	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	2.96e-06	2.66e-05	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—CYP1A1—liver cancer	2.95e-06	2.65e-05	CbGpPWpGaD
Progesterone—SLC22A1—Metabolism—PIK3CB—liver cancer	2.95e-06	2.65e-05	CbGpPWpGaD
Progesterone—ABCB11—Metabolism—PIK3CA—liver cancer	2.95e-06	2.64e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—GOT1—liver cancer	2.94e-06	2.64e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—GGT1—liver cancer	2.94e-06	2.64e-05	CbGpPWpGaD
Progesterone—CYP2A6—Metabolism—PIK3CB—liver cancer	2.91e-06	2.61e-05	CbGpPWpGaD
Progesterone—CYP3A5—Metabolism—PPARG—liver cancer	2.89e-06	2.59e-05	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—CYP1A1—liver cancer	2.88e-06	2.58e-05	CbGpPWpGaD
Progesterone—ABCC1—Disease—KRAS—liver cancer	2.88e-06	2.58e-05	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—GSTM1—liver cancer	2.86e-06	2.57e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—VEGFA—liver cancer	2.85e-06	2.55e-05	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—GSTM1—liver cancer	2.84e-06	2.55e-05	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—PIK3CA—liver cancer	2.84e-06	2.54e-05	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism—PIK3CG—liver cancer	2.82e-06	2.53e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—STAT3—liver cancer	2.82e-06	2.53e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—RAF1—liver cancer	2.8e-06	2.51e-05	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—MTHFR—liver cancer	2.75e-06	2.47e-05	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—TP53—liver cancer	2.75e-06	2.46e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—MTOR—liver cancer	2.73e-06	2.45e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—PIK3CB—liver cancer	2.73e-06	2.45e-05	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism—PPARG—liver cancer	2.73e-06	2.44e-05	CbGpPWpGaD
Progesterone—AR—Gene Expression—AKT1—liver cancer	2.72e-06	2.44e-05	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	2.72e-06	2.44e-05	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—CYP1A1—liver cancer	2.71e-06	2.43e-05	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—PSMA4—liver cancer	2.7e-06	2.42e-05	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—PSMD10—liver cancer	2.7e-06	2.42e-05	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—PPARA—liver cancer	2.7e-06	2.42e-05	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—CYP1A1—liver cancer	2.69e-06	2.41e-05	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—MTHFR—liver cancer	2.69e-06	2.41e-05	CbGpPWpGaD
Progesterone—ABCC1—Disease—PIK3CA—liver cancer	2.65e-06	2.37e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—GSTP1—liver cancer	2.64e-06	2.37e-05	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—PPARA—liver cancer	2.63e-06	2.36e-05	CbGpPWpGaD
Progesterone—CYP3A5—Metabolism—PIK3CD—liver cancer	2.63e-06	2.36e-05	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—GOT2—liver cancer	2.63e-06	2.36e-05	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—HRAS—liver cancer	2.63e-06	2.35e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—MYC—liver cancer	2.62e-06	2.35e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—TGFB1—liver cancer	2.61e-06	2.34e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—HMOX1—liver cancer	2.6e-06	2.33e-05	CbGpPWpGaD
Progesterone—CYP3A5—Metabolism—ALB—liver cancer	2.59e-06	2.33e-05	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism—PIK3CG—liver cancer	2.59e-06	2.32e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—CDKN1B—liver cancer	2.56e-06	2.3e-05	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—MTHFR—liver cancer	2.53e-06	2.27e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—CASP3—liver cancer	2.51e-06	2.25e-05	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—IL6—liver cancer	2.51e-06	2.25e-05	CbGpPWpGaD
Progesterone—SLC22A3—Metabolism—AKT1—liver cancer	2.51e-06	2.25e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—IL2—liver cancer	2.51e-06	2.25e-05	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—MTHFR—liver cancer	2.51e-06	2.25e-05	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism—PPARG—liver cancer	2.5e-06	2.24e-05	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism—PIK3CD—liver cancer	2.48e-06	2.23e-05	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—PPARA—liver cancer	2.48e-06	2.23e-05	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—CYP2E1—liver cancer	2.47e-06	2.22e-05	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—PPARA—liver cancer	2.46e-06	2.21e-05	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism—ALB—liver cancer	2.45e-06	2.2e-05	CbGpPWpGaD
Progesterone—ABCC1—Disease—HRAS—liver cancer	2.45e-06	2.19e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—CCND1—liver cancer	2.45e-06	2.19e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—JUN—liver cancer	2.44e-06	2.19e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—GSTM1—liver cancer	2.43e-06	2.18e-05	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	2.42e-06	2.17e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—CTNNB1—liver cancer	2.42e-06	2.17e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—KRAS—liver cancer	2.42e-06	2.17e-05	CbGpPWpGaD
Progesterone—ABCB11—Metabolism—AKT1—liver cancer	2.41e-06	2.16e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—MMP9—liver cancer	2.37e-06	2.13e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—CDKN1A—liver cancer	2.37e-06	2.12e-05	CbGpPWpGaD
Progesterone—ABCC1—Disease—IL6—liver cancer	2.34e-06	2.1e-05	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—AKT1—liver cancer	2.32e-06	2.08e-05	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—PIK3CG—liver cancer	2.31e-06	2.07e-05	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—CYCS—liver cancer	2.31e-06	2.07e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—MAPK8—liver cancer	2.31e-06	2.07e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—CYP1A1—liver cancer	2.3e-06	2.06e-05	CbGpPWpGaD
Progesterone—CYP3A5—Metabolism—PIK3CB—liver cancer	2.29e-06	2.05e-05	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism—PIK3CD—liver cancer	2.28e-06	2.04e-05	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—GGT1—liver cancer	2.27e-06	2.03e-05	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—GOT1—liver cancer	2.27e-06	2.03e-05	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—PIK3CG—liver cancer	2.26e-06	2.02e-05	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism—ALB—liver cancer	2.25e-06	2.02e-05	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—PPARG—liver cancer	2.23e-06	2e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—PIK3CA—liver cancer	2.22e-06	1.99e-05	CbGpPWpGaD
Progesterone—ABCC1—Metabolism—PIK3CA—liver cancer	2.22e-06	1.99e-05	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	2.21e-06	1.98e-05	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—PPARG—liver cancer	2.18e-06	1.95e-05	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism—PIK3CB—liver cancer	2.16e-06	1.94e-05	CbGpPWpGaD
Progesterone—ABCC1—Disease—AKT1—liver cancer	2.16e-06	1.94e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—TP53—liver cancer	2.15e-06	1.93e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—MTHFR—liver cancer	2.14e-06	1.92e-05	CbGpPWpGaD
Progesterone—CYP1B1—Metabolism—PIK3CA—liver cancer	2.14e-06	1.92e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—VEGFA—liver cancer	2.13e-06	1.91e-05	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—PIK3CG—liver cancer	2.13e-06	1.91e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—STAT3—liver cancer	2.11e-06	1.89e-05	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—PIK3CG—liver cancer	2.11e-06	1.89e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—PPARA—liver cancer	2.1e-06	1.89e-05	CbGpPWpGaD
Progesterone—ESR1—Gene Expression—AKT1—liver cancer	2.09e-06	1.88e-05	CbGpPWpGaD
Progesterone—NR3C1—Gene Expression—AKT1—liver cancer	2.06e-06	1.85e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—HRAS—liver cancer	2.06e-06	1.84e-05	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—PPARG—liver cancer	2.05e-06	1.84e-05	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—GSTP1—liver cancer	2.04e-06	1.83e-05	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—PPARG—liver cancer	2.03e-06	1.82e-05	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—PIK3CD—liver cancer	2.03e-06	1.82e-05	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—HMOX1—liver cancer	2.01e-06	1.8e-05	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—ALB—liver cancer	2.01e-06	1.8e-05	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism—PIK3CB—liver cancer	1.98e-06	1.78e-05	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—PIK3CD—liver cancer	1.98e-06	1.78e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—IL6—liver cancer	1.97e-06	1.76e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—MYC—liver cancer	1.96e-06	1.76e-05	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—ALB—liver cancer	1.96e-06	1.76e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—TGFB1—liver cancer	1.96e-06	1.76e-05	CbGpPWpGaD
Progesterone—CYP3A7—Metabolism—PIK3CA—liver cancer	1.93e-06	1.73e-05	CbGpPWpGaD
Progesterone—SLC22A2—Metabolism—PIK3CA—liver cancer	1.93e-06	1.73e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	1.89e-06	1.69e-05	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—GSTM1—liver cancer	1.87e-06	1.68e-05	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—PIK3CD—liver cancer	1.87e-06	1.68e-05	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—PIK3CD—liver cancer	1.85e-06	1.66e-05	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—ALB—liver cancer	1.85e-06	1.65e-05	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—ALB—liver cancer	1.83e-06	1.64e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—AKT1—liver cancer	1.82e-06	1.63e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—KRAS—liver cancer	1.81e-06	1.63e-05	CbGpPWpGaD
Progesterone—ABCC1—Metabolism—AKT1—liver cancer	1.81e-06	1.62e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—PIK3CG—liver cancer	1.8e-06	1.62e-05	CbGpPWpGaD
Progesterone—SLC22A1—Metabolism—PIK3CA—liver cancer	1.8e-06	1.61e-05	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—CYP1A1—liver cancer	1.77e-06	1.59e-05	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—PIK3CB—liver cancer	1.77e-06	1.59e-05	CbGpPWpGaD
Progesterone—CYP2A6—Metabolism—PIK3CA—liver cancer	1.77e-06	1.59e-05	CbGpPWpGaD
Progesterone—CYP1B1—Metabolism—AKT1—liver cancer	1.75e-06	1.57e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—PPARG—liver cancer	1.74e-06	1.56e-05	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—PIK3CB—liver cancer	1.73e-06	1.55e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—PIK3CA—liver cancer	1.67e-06	1.49e-05	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—MTHFR—liver cancer	1.65e-06	1.48e-05	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—PIK3CB—liver cancer	1.63e-06	1.46e-05	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—PPARA—liver cancer	1.62e-06	1.46e-05	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—PIK3CB—liver cancer	1.62e-06	1.45e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—TP53—liver cancer	1.61e-06	1.44e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—PIK3CD—liver cancer	1.58e-06	1.42e-05	CbGpPWpGaD
Progesterone—CYP3A7—Metabolism—AKT1—liver cancer	1.58e-06	1.42e-05	CbGpPWpGaD
Progesterone—SLC22A2—Metabolism—AKT1—liver cancer	1.58e-06	1.41e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—ALB—liver cancer	1.56e-06	1.4e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—HRAS—liver cancer	1.54e-06	1.38e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—IL6—liver cancer	1.47e-06	1.32e-05	CbGpPWpGaD
Progesterone—SLC22A1—Metabolism—AKT1—liver cancer	1.47e-06	1.32e-05	CbGpPWpGaD
Progesterone—CYP2A6—Metabolism—AKT1—liver cancer	1.45e-06	1.3e-05	CbGpPWpGaD
Progesterone—CYP3A5—Metabolism—PIK3CA—liver cancer	1.4e-06	1.25e-05	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—PIK3CG—liver cancer	1.39e-06	1.25e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—PIK3CB—liver cancer	1.38e-06	1.24e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—AKT1—liver cancer	1.36e-06	1.22e-05	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—PPARG—liver cancer	1.34e-06	1.2e-05	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism—PIK3CA—liver cancer	1.32e-06	1.18e-05	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—PIK3CD—liver cancer	1.22e-06	1.1e-05	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism—PIK3CA—liver cancer	1.21e-06	1.08e-05	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—ALB—liver cancer	1.21e-06	1.08e-05	CbGpPWpGaD
Progesterone—CYP3A5—Metabolism—AKT1—liver cancer	1.14e-06	1.02e-05	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—PIK3CA—liver cancer	1.08e-06	9.68e-06	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism—AKT1—liver cancer	1.08e-06	9.67e-06	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—PIK3CB—liver cancer	1.07e-06	9.55e-06	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—PIK3CA—liver cancer	1.05e-06	9.45e-06	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—PIK3CA—liver cancer	9.93e-07	8.91e-06	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism—AKT1—liver cancer	9.88e-07	8.86e-06	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—PIK3CA—liver cancer	9.85e-07	8.83e-06	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—AKT1—liver cancer	8.82e-07	7.91e-06	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—AKT1—liver cancer	8.61e-07	7.72e-06	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—PIK3CA—liver cancer	8.41e-07	7.54e-06	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—AKT1—liver cancer	8.11e-07	7.28e-06	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—AKT1—liver cancer	8.04e-07	7.21e-06	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—AKT1—liver cancer	6.87e-07	6.16e-06	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—PIK3CA—liver cancer	6.49e-07	5.82e-06	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—AKT1—liver cancer	5.3e-07	4.76e-06	CbGpPWpGaD
